Maximus (NYSE:MMS) Upgraded to Buy at Wall Street Zen

Maximus (NYSE:MMS) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday.

MMS has been the subject of several other reports. Zacks Research cut shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings cut shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has a consensus rating of “Hold”.

Maximus Price Performance

MMS stock opened at $60.49 on Friday. The company has a fifty day moving average price of $63.79 and a 200-day moving average price of $76.61. The company has a market capitalization of $3.18 billion, a P/E ratio of 9.06 and a beta of 0.58. Maximus has a 52-week low of $56.92 and a 52-week high of $100.00. The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.21 and a current ratio of 2.21.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, topping the consensus estimate of $1.98 by $0.09. Maximus had a net margin of 7.02% and a return on equity of 25.10%. The company had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.32 billion. During the same period in the prior year, the company posted $2.01 earnings per share. Maximus’s revenue for the quarter was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. As a group, equities analysts expect that Maximus will post 8.43 EPS for the current year.

Insider Buying and Selling

In other Maximus news, Director Jan Madsen sold 742 shares of the firm’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total value of $53,609.50. Following the completion of the sale, the director directly owned 20,795 shares in the company, valued at approximately $1,502,438.75. This trade represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.80% of the company’s stock.

Institutional Investors Weigh In On Maximus

Large investors have recently bought and sold shares of the stock. JPMorgan Chase & Co. grew its holdings in Maximus by 19.8% in the third quarter. JPMorgan Chase & Co. now owns 200,331 shares of the health services provider’s stock worth $18,304,000 after purchasing an additional 33,136 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Maximus by 2.0% during the third quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider’s stock valued at $170,812,000 after buying an additional 36,989 shares during the last quarter. Divisadero Street Capital Management LP grew its holdings in shares of Maximus by 93.5% during the third quarter. Divisadero Street Capital Management LP now owns 183,872 shares of the health services provider’s stock valued at $16,800,000 after buying an additional 88,872 shares during the last quarter. WINTON GROUP Ltd acquired a new position in shares of Maximus during the third quarter valued at about $6,208,000. Finally, Assenagon Asset Management S.A. acquired a new position in shares of Maximus during the fourth quarter valued at about $15,673,000. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.